Home Markers of Bone Turnover in Postmenopausal Women Receiving Hormone Replacement Therapy
Article
Licensed
Unlicensed Requires Authentication

Markers of Bone Turnover in Postmenopausal Women Receiving Hormone Replacement Therapy

  • Ahmad Hamwi , Abdel-Halim Ganem , Christina Grebe , Katharina Kerschan-Schindl , Elisabeth Preisinger , Ewald Boschitsch and Christian Bieglmayer
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 39 Issue 5

Abstract

We investigated the effects of hormone replacement therapy (n = 27) on biochemical markers of bone turnover in a cross-sectional study of 127 postmenopausal women (according to WHO guidelines 18 patients had normal bone mineral density and 109 suffered from bone loss). Urinary excretion of free deoxypyridinoline and C- or N-telopeptide fragments of type I collagen served as bone resorption markers, serum osteocalcin as a bone formation marker. In women with no hormone replacement therapy, only C-and N-telopeptides correlated significantly with the lumbal T-score as an index for bone mineral density. Patients with bone loss receiving hormone replacement therapy exhibited significantly lower C-telopeptide, N-telopeptide and osteocalcin levels than those with no therapy (mean −45%, −43% and −26%, respectively), while deoxypyridinoline showed no significant differences. Among the markers investigated, C- and N-telopeptides seemed to be more reliable to detect therapeutic effects on bone metabolism. We present a preliminary model to evaluate bone turnover and resorption/formation rate.

:
Published Online: 2005-06-01
Published in Print: 2001-06-06

Copyright © 2001 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. SIBioC 2001 33rd National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology
  2. CCLM: The Near Future
  3. Granulocyte-Colony Stimulating Factor and Macrophage-Colony Stimulating Factor in Patients with Non-Small-Cell Lung Cancer
  4. Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis
  5. Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for the Measurement of Prostate-Specific Antigen mRNA in the Peripheral Blood of Patients with Prostate Carcinoma Using the TaqManTM Detection System
  6. Serum Cardiac Troponin I after Conventional and Minimal Invasive Coronary Artery Bypass Surgery
  7. Improvement of the Quantitative Method for Glucose Determination Using Hexokinase and Glucose 6-Phosphate Dehydrogenase
  8. Conditions for Single-Strand Conformation Polymorphism (SSCP) Analysis of BRCA1 Gene Using an Automated Electrophoresis Unit
  9. Discrepancies between Apolipoprotein E Phenotyping and Genotyping in the Elderly
  10. Markers of Bone Turnover in Postmenopausal Women Receiving Hormone Replacement Therapy
  11. Reference Intervals for the Markers of Proteinuria with a Standardised Bed-Rest Collection of Urine
  12. The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations
  13. The White Blood Cell Differential: Three Methods Compared
  14. Plasma Brain Natriuretic Peptide Measured by Fully-Automated Immunoassay and by Immunoradiometric Assay Compared
  15. Length of Sedimentation Reaction in Undiluted Blood (Erythrocyte Sedimentation Rate): Variations with Sex and Age and Reference Limits
  16. Biochemical Analysis of the Sperm and Infertility
  17. Evaluation of a Rapid Bedside Immunochromatographic Assay for Detection of Cardiac Troponin I in Whole Blood
  18. Correct Graphic Presentation of Method Comparison Data
  19. European Symposium on Clinical Laboratory and In Vitro Diagnostics Industry
Downloaded on 7.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2001.066/html
Scroll to top button